Russell Alan J. - 30 Nov 2021 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Chief Scientific Officer, Director
Signature: /s/ John R. Moore, Attorney-in-Fact for Russell Alan J
Issuer symbol: EWTX
Transactions as of: 30 Nov 2021
Net transactions value: +$37,815
Form type: 4
Filing time: 01 Dec 2021, 17:20:14 UTC
Previous filing: 17 Nov 2021
Next filing: 03 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Options Exercise	$26,565	+147,585		$0.1800^*	147,585	30 Nov 2021	Direct
transaction	EWTX	Common Stock	Options Exercise	$11,250	+25,000	+17%	$0.4500^*	172,585	30 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Stock Option (Right to Buy)	Options Exercise	$0	-147,585	-100%	$0.000000^*	0	30 Nov 2021	Common Stock	147,585	$0.1800	Direct	F1
transaction	EWTX	Stock Option (Right to Buy)	Options Exercise	$0	-25,000	-16%	$0.000000	130,352	30 Nov 2021	Common Stock	25,000	$0.4500	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option vested on July 27, 2018 and 1/48th of the shares subject to the option vested each month thereafter.
F2	1/48th of the shares subject to the option vested on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.